461030.KQ
IMBdx
KOE · Healthcare · Biotechnology · KR
KRW 2,960.00
+0.00%Margins
Gross margin
22.7%
EBITDA margin
-126.1%
EBIT margin
-153.8%
Net margin
-135.5%
FCF margin
-138.8%
-32.6%
Return on equity
-30.8%
Return on assets
-36.4%
Return on invested capital
0.22x
Asset turnover
-KRW 7.0B
Cash from operations
KRW 1.3K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026